Feed Articles

€38.8bn in orders and a new EUV cycle: why ASML’s growth case now stretches to 2028

BR
Bulios Research Team
· · 12 min read

It is tempting to reduce ASML to a single argument: the company dominates the most advanced lithography. But the stock does not move on technological leadership alone. It moves on the investment rhythm of a small set of customers and on how aggressively they expand capacity for the next node.

That is why the late-year signal mattered. The discussion shifted from general AI excitement to a concrete indicator: €38.8bn in orders, consistent with planning that is speeding up again for the next generation of fabs. When orders start to confirm the capex cycle, ASML stops being a “quality hold” and starts being priced as a multi-year growth compounder again.

Top points of analysis

  • Orders jumped to €13.2bn in Q4 2025, of which EUV was €7.4bn - the type of signal that typically outpaces sales by several quarters.

  • Backlog reached €38.8bn.

  • The firm targets 2026 revenues of €34-39bn at gross margins of 51-53%, while the customer investment cycle continues to be fed by AI and more demanding production…

Bulios Black

Finish the whole article

And you can also ask StockBot what it means for your own stocks.

What does it mean for my stocks?
Unlock StockBot's answer

Black membership: analyses, screener, newsletters and unlimited StockBot.

4.45 · +200K investors in the community

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy